TFS HealthScience, a portfolio company of investment firm Ratos, has entered into a partnership with biotech company Verigraft to support a pivotal Phase 2/3 study of the personalized vascular therapy P-TEV, according to a press release.
TFS HealthScience will provide full-service clinical research support for the study, which is designed to evaluate the safety, function, and long-term performance of the treatment in a larger patient cohort. The study focuses on advanced therapy medicinal products (ATMPs).
'We are proud that this collaboration underscores TFS HealthScience's ability to execute complex clinical trials and support the development of innovative treatments that address significant medical needs', says Gustaf Salford, CEO of Ratos.
Ratos holds a 100 percent stake in TFS HealthScience.
Ratos AB is a Sweden-based private equity company. It owns and develops over 10 unlisted medium-sized enterprises in Nordic region. Enterprises are active in various sectors, such as industry, consumer goods, services and life science, among others. The Company’s portfolio comprises Aibel, the supplier of maintenance and modification services for production platforms and onshore installations within oil and gas industry; Bisnode, the data and analytics company; HENT, the construction company with focus on public and commercial real estate; Plantasjen, the chain for sales of plants and gardening accessories; HL Display, the supplier of products and solutions for in-store communication and merchandising; and Diab, the manufacturer of materials for sandwich composite structures, among others enterprises.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
